Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087675493> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2087675493 abstract "Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, ILBackground &Aims: Curcumin, a polyphenol derived from Curcuma Longa is known for his anti-cancer activity and may exert synergic effects with cytotoxic agents. In parallel, neuroendocrine differentiation in castration-resistant prostate cancer provides an aggressive phenotype to disease. In this prospective phase II study, we assessed the impact of a new combination, docetaxel plus curcumin, in patients with or without neuroendocrine features. Methods: In this phase II study, thirty patients received docetaxel 75 mg/m*2 (perfusion given every 3 weeks) in combination with curcumin orally at 6 g/day (day-4 to day+2 of docetaxel). Neuroendocrine features were determined by serum chromogranin A and neuron-specific enolase, before each cycle. Variations were divided in 3 groups: an increase > 25%, a decrease of 50% or greater and stability. Treatment response were measured by PSA >50% decrease (PSA response) and objective response rate on evaluable metastatic lesions. Results: Initially, 53% of patients had an elevated chromogranin A and 33% an elevated neuron-specific enolase. During treatment, 7% performed a > 50% chromogranin A decrease and 30% a neuron-specific enolase decrease. PSA response was observed in 59% of patients and 40% out of patients with evaluable targets had a partial response. PSA and objective response rate were identical whatever neuroendocrine feature. A positive correlation was found between chromogranin A and PSA, age, weight and palliative radiotherapy. Conversely, neuron-specific enolase was negatively correlated with PSA and patients'age. Conclusions: Curcumin and docetaxel had a global action on tumors with or without neuroendocrine features. Chromogranin A was the best neuroendocrine marker in correlation with clinical parameters. This association delivered then remarkable results on neuroendocrine differentiation of castration-resistant prostate cancer, in comparison with pivotal study data with docetaxel alone (TAX 327).Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2694. doi:1538-7445.AM2012-2694" @default.
- W2087675493 created "2016-06-24" @default.
- W2087675493 creator A5003470485 @default.
- W2087675493 creator A5029086962 @default.
- W2087675493 creator A5030260555 @default.
- W2087675493 creator A5030329962 @default.
- W2087675493 creator A5034429722 @default.
- W2087675493 creator A5040169609 @default.
- W2087675493 creator A5043665560 @default.
- W2087675493 creator A5064696564 @default.
- W2087675493 creator A5065588744 @default.
- W2087675493 creator A5077857574 @default.
- W2087675493 date "2012-04-15" @default.
- W2087675493 modified "2023-10-18" @default.
- W2087675493 title "Abstract 2694: The impact of curcumin plus docetaxel on neuroendocrine features, or not, in castration-resistant prostate cancer: A prospective study" @default.
- W2087675493 doi "https://doi.org/10.1158/1538-7445.am2012-2694" @default.
- W2087675493 hasPublicationYear "2012" @default.
- W2087675493 type Work @default.
- W2087675493 sameAs 2087675493 @default.
- W2087675493 citedByCount "0" @default.
- W2087675493 crossrefType "proceedings-article" @default.
- W2087675493 hasAuthorship W2087675493A5003470485 @default.
- W2087675493 hasAuthorship W2087675493A5029086962 @default.
- W2087675493 hasAuthorship W2087675493A5030260555 @default.
- W2087675493 hasAuthorship W2087675493A5030329962 @default.
- W2087675493 hasAuthorship W2087675493A5034429722 @default.
- W2087675493 hasAuthorship W2087675493A5040169609 @default.
- W2087675493 hasAuthorship W2087675493A5043665560 @default.
- W2087675493 hasAuthorship W2087675493A5064696564 @default.
- W2087675493 hasAuthorship W2087675493A5065588744 @default.
- W2087675493 hasAuthorship W2087675493A5077857574 @default.
- W2087675493 hasConcept C121608353 @default.
- W2087675493 hasConcept C126322002 @default.
- W2087675493 hasConcept C126894567 @default.
- W2087675493 hasConcept C143998085 @default.
- W2087675493 hasConcept C188618488 @default.
- W2087675493 hasConcept C204232928 @default.
- W2087675493 hasConcept C2778250585 @default.
- W2087675493 hasConcept C2780192828 @default.
- W2087675493 hasConcept C2780341458 @default.
- W2087675493 hasConcept C2781190966 @default.
- W2087675493 hasConcept C71924100 @default.
- W2087675493 hasConcept C77231918 @default.
- W2087675493 hasConcept C90924648 @default.
- W2087675493 hasConcept C98274493 @default.
- W2087675493 hasConceptScore W2087675493C121608353 @default.
- W2087675493 hasConceptScore W2087675493C126322002 @default.
- W2087675493 hasConceptScore W2087675493C126894567 @default.
- W2087675493 hasConceptScore W2087675493C143998085 @default.
- W2087675493 hasConceptScore W2087675493C188618488 @default.
- W2087675493 hasConceptScore W2087675493C204232928 @default.
- W2087675493 hasConceptScore W2087675493C2778250585 @default.
- W2087675493 hasConceptScore W2087675493C2780192828 @default.
- W2087675493 hasConceptScore W2087675493C2780341458 @default.
- W2087675493 hasConceptScore W2087675493C2781190966 @default.
- W2087675493 hasConceptScore W2087675493C71924100 @default.
- W2087675493 hasConceptScore W2087675493C77231918 @default.
- W2087675493 hasConceptScore W2087675493C90924648 @default.
- W2087675493 hasConceptScore W2087675493C98274493 @default.
- W2087675493 hasLocation W20876754931 @default.
- W2087675493 hasOpenAccess W2087675493 @default.
- W2087675493 hasPrimaryLocation W20876754931 @default.
- W2087675493 hasRelatedWork W1875869773 @default.
- W2087675493 hasRelatedWork W1965658313 @default.
- W2087675493 hasRelatedWork W1986092309 @default.
- W2087675493 hasRelatedWork W2038888590 @default.
- W2087675493 hasRelatedWork W2039129728 @default.
- W2087675493 hasRelatedWork W2044073809 @default.
- W2087675493 hasRelatedWork W2074429860 @default.
- W2087675493 hasRelatedWork W2084745398 @default.
- W2087675493 hasRelatedWork W2119402609 @default.
- W2087675493 hasRelatedWork W2121800941 @default.
- W2087675493 hasRelatedWork W2257094653 @default.
- W2087675493 hasRelatedWork W2325702433 @default.
- W2087675493 hasRelatedWork W2395453318 @default.
- W2087675493 hasRelatedWork W2408135209 @default.
- W2087675493 hasRelatedWork W2605602003 @default.
- W2087675493 hasRelatedWork W2794223852 @default.
- W2087675493 hasRelatedWork W2891415245 @default.
- W2087675493 hasRelatedWork W3004789363 @default.
- W2087675493 hasRelatedWork W3038718086 @default.
- W2087675493 hasRelatedWork W3111027555 @default.
- W2087675493 isParatext "false" @default.
- W2087675493 isRetracted "false" @default.
- W2087675493 magId "2087675493" @default.
- W2087675493 workType "article" @default.